A recent study (Souza et al., 2010) found evidence for genetic associations between GFRA1 and 3 and schizophrenia, as well as evidence for GFRA2 variants modulating the therapeutic response to clozapine. The gene discussed is GFRA2; the disease is schizophrenia.